Document is current

Any future updates will be listed below

Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro

Crossref DOI link: https://doi.org/10.1038/leu.2014.235

Published Online: 2014-07-31

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark